Grace Therapeutics Patents – Insights & Stats (Updated 2023)

Grace Therapeutics has a total of 20 patents globally, out of which 2 have been granted. Of these 20 patents, more than 60% patents are active. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Grace Therapeutics.

Grace Therapeutics was founded in the year 2014. The Company is a pharmaceutical company with a focus on rare and orphan diseases. Company’s strategy is to develop novel delivery technologies that dramatically improve the clinical outcomes of drugs previously approved for use in humans. Its selective pipeline screening model supports the development of differentiated products with a unique evidence-based and outcomes-driven value proposition.

Do read about some of the most popular patents of Grace Therapeutics which have been covered by us in this article and also you can find Grace Therapeutics patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Grace Therapeutics patent portfolio.

How many patents does the founder of Grace Therapeutics have?

The founder George Kottayil has 0 patent and Vimal Kavuru has 5 patents.

How many patents does Grace Therapeutics have?

Grace Therapeutics has a total of 20 patents globally. These patents belong to 5 unique patent families. Out of 20 patents, 12 patents are active.

How Many Patents did Grace Therapeutics File Every Year?

Grace Therapeutics Patent Filing Trend

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.

Year of Patents Filing or GrantGrace Therapeutics Applications FiledGrace Therapeutics Patents Granted
20232
202221
20211
20201
20192
20176
20167

How many Grace Therapeutics patents are Alive/Dead?

Grace Therapeutics Patent Portfolio

How Many Patents did Grace Therapeutics File in Different Countries?

Grace Therapeutics Worldwide Patent Filing

Countries in which Grace Therapeutics Filed Patents

CountryPatents
Canada4
United States Of America4
Hong Kong (S.A.R.)4
China3
Eurasia1
Korea (South)1

Where are Research Centres of Grace Therapeutics Patents Located?

The Research Centre for all the Grace Therapeutics patents is the United States of America.

Best Grace Therapeutics Patents

US20170296485A1 is the most popular patent in the Grace Therapeutics portfolio. It has received 5 citations so far from companies like Inclusion GmbH, Celista Pharmaceuticals Llc and Kobayashi Pharmaceutical Co., Ltd.

What Percentage of Grace Therapeutics US Patent Applications were Granted?

Grace Therapeutics (Excluding its subsidiaries) has filed 14 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 6 have been granted leading to a grant rate of 60.0%.

Below are the key stats of Grace Therapeutics patent prosecution at the USPTO.

Which Law Firms Filed Most US Patents for Grace Therapeutics?

Law FirmTotal ApplicationsSuccess Rate
Davidson Davidson & Kappel Llc1460.00%

List of Grace Therapeutics Patents

Grace Therapeutics PatentsTitle
CN108738309BSprays That Form A Topical Film
CN114886850ANimodipine Formulations And Methods Of Treating Conditions
CA3005150CTopical Film-Forming Spray
CA3122363A1Therapeutic Composition Of Intranasal Lidocaine
CA3021237A1Stable Nimodipine Parenteral Formulation
CA3011015A1Betamethasone Oral Spray Formulation And Method Of Use To Treat Ataxia
HK40077694AStable Nimodipine Parenteral Formulation
HK40077176ANimodipine Formulation And Method Of Treating Conditions
HK40063645ATherapeutic Composition Of Intranasal Lidocaine
HK40062158ATherapeutic Composition Of Intranasal Lidocaine
EA201891225A1Film-Forming Spray For Topical Application
KR1020180088415ATopical Film-Forming Spray
US20200397769A1Stable Nimodipine Parenteral Formulation
US20190255033A1Stable Nimodipine Parenteral Formulation
US20170296484A1Topical Film-Forming Spray
US20170296485A1Topical Film-Forming Spray
CN109069651AStable Nimopidine Parenteral Formulation
WO2017091739A8Topical Film-Forming Spray
WO2017180718A1Stable Nimopidine Parenteral Formulation
WO2017123744A1Betamethasone Oral Spray Formulation And Method Of Use To Treat Ataxia

What are Grace Therapeutics key innovation segments?

What Technologies are Covered by Grace Therapeutics?

The chart below distributes patents filed by Grace Therapeutics in different countries on the basis of the technology protected in patents. It also represents the markets where Grace Therapeutics thinks it’s important to protect particular technology inventions.

R&D Focus: How has Grace Therapeutics search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!

Interested in knowing about the areas of innovation that are being protected by Grace Therapeutics?

Related Articles

MRM Patents – Insights & Stats (Updated 2024)

MRM has a total of 112 patents globally, out of which 64 have been granted. Of these 112 patents, more than 73% patents are active. United States of America is where MRM has filed the maximum number of patents, followed by China and Australia. Parallelly, Australia seems to be the

Read More »

I Peace Patents – Insights & Stats (Updated 2024)

I Peace has a total of 260 patents globally, out of which 53 have been granted. Of these 260 patents, more than 75% patents are active. Japan is where I Peace has filed the maximum number of patents, followed by The United States of America and Hong Kong (S.A.R.). Parallelly,

Read More »

Leave a Comment

Fill the form to get the details:

Our comprehensive report provides an in-depth look into the patent portfolio. The report includes a breakdown of the patent portfolio across various technologies, listing the patent along with brief summaries of each patent's technology.